Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...

Dangerous products are far more common than they should be. Despite manufacturers’ and retailers’ obligations to avoid ...

With the FDA's new requirements for premarket submission and ongoing monitoring by medical device manufacturers in place, ...

The emergence of adaptive cardiac devices, especially those that utilise AI, is propelling the wider industry shift towards ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosisalfapump® is ...

Microtech has commenced human clinical trials of its implantable microsensor platform, aimed at measuring atrial pressures ...

Northwestern University scientists have designed a new implantable device that can monitor fluctuating levels of proteins within the body in real time. Inspired by fruit shaking off the branches ...

A total of 801 devices were explanted. The manufacturers of the explanted generators were Medtronic (MDT; 454), Boston Scientific/Guidant (BS)/(GDT; 255), St. Jude Medical (SJM; 73 [St. Paul ...

Artivion, a medical device company that manufactures implantable tissues for cardiac and vascular transplant applications, says its services have been “disrupted” due to a cybersecurity incident.